Akero Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Akero Therapeutics, Inc. has filed 734 SEC EDGAR filings since 18 Dec 2018

SEC filing history

Showing 376-400 of 734 matching filings.

Per page
25
Current page
16
424B5 File 333-256229

424B5

Filing date
17 May 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 May 2023
Reporting date
18 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-38944

ARS

Filing date
28 Apr 2023
Reporting date
31 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-38944

DEF 14A

Filing date
28 Apr 2023
Reporting date
23 Jun 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91047

AKERO THERAPEUTICS, INC.

Filing date
10 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
05 Apr 2023
Reporting date
03 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 001-38944

144 filing

Filing date
03 Apr 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-270662

S-8

Filing date
17 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-256229

424B5

Filing date
17 Mar 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Mar 2023
Reporting date
10 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Mar 2023
Reporting date
10 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Mar 2023
Reporting date
10 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Mar 2023
Reporting date
10 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Mar 2023
Reporting date
10 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Mar 2023
Reporting date
01 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91047

AMENDMENT TO FORM SC 13G

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-91047

SC 13G

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-91047

SCHEDULE 13G/A, AMENDMENT #2

Filing date
14 Feb 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .